Rate My Professor Olivia Bupha-Intr

Bupha-Intr's scholarly contributions focus on antimicrobial stewardship, bacterial and fungal infections, and management in immunocompromised hosts. Key publications include 'CAR-T cell therapy and infection: a review' (2021, Expert Review of Anti-infective Therapy), where she reviewed infection risks post-CAR-T therapy; 'Efficacy of Early Oral Switch with β-Lactams for Low-Risk Staphylococcus aureus Bacteremia' (2020, Antimicrobial Agents and Chemotherapy), assessing safety of abbreviated intravenous therapy; and '[18F]FDG-PET-CT compared with CT for persistent or recurrent infection following curative therapy for lymphoma' (2022, The Lancet Haematology). She co-authored consensus guidelines such as 'Consensus guidelines for the diagnosis and management of invasive fungal infections in adults in Australia and New Zealand' (2021, Internal Medicine Journal), 'Consensus guidelines for the subsequent management of neutropenic fever after empiric antimicrobial therapy in adults' (2025), and 'Current Practice Patterns and Educational Needs of Invasive Fungal Disease Management' (2025, Transplant Infectious Disease). Additional works encompass 'A triple bottom line approach to antimicrobial stewardship: the effects of simplifying treatment' (2023, medRxiv) and 'Antimicrobial stewardship in human healthcare in Aotearoa New Zealand: urgent call for national leadership and co-ordinated effort' (2021, New Zealand Medical Journal). Earlier publications from her medical training include 'Prostate cancer--are ethnic minorities disadvantaged?' (2008, Anticancer Research) and 'Are at-risk New Zealand women receiving recommended cardiovascular preventive therapy?' (2010, New Zealand Medical Journal). She has supervised University of Otago summer scholarship students, including Katie Reed, whose project on HIV care received first prize in 2022, and others highly commended for research on infections.